Jacquie Beltrao issued a huge announcement five years after she was told she had stage four breast cancer. The Sky News ...

Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...

In May, the FDA granted significant drug approvals across various therapeutic areas, marking notable progress in expanding treatment options for patients.

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Rising temperatures are linked to increases in the prevalence and mortality of breast, ovarian, uterine, and cervical cancers ...

Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.

Wednesday night, Kari Gossvener and her son Zain Braden helped kick off Game One of the Women's College World Series in Oklahoma City, with Zain performing ...

Jay Harris, who has anchored for SportsCenter for over 10 years has shared he has been diagnosed with prostate cancer and ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...

China’s NMPA has approved Akeso's PD-1/CTLA-4 bispecific antibody, cadonilimab, to treat persistent, recurrent or metastatic ...